Transactivation of cell death signals by glutamate transmission in dopaminergic neurons

Critical Reviews in Neurobiology

Volumn 16, Issue 1-2, 2004, Pages 107-119

  De Erausquin, Gabriel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Dopaminergic neurons; Excitotoxicity; Neuronal death; Nuclear factor kappa B (NF B)

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53;

CALCIUM HOMEOSTASIS; CELL DEATH; CONCENTRATION RESPONSE; DOPAMINERGIC SYSTEM; HUMAN; IN VITRO STUDY; MESENCEPHALON; NERVE CELL; NEURITE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN PROCESSING; RECEPTOR UPREGULATION; REVIEW; SCHIZOPHRENIA; TISSUE CULTURE; TRANSACTIVATION;

ANIMALS; CELL DEATH; DOPAMINE; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; HUMANS; NEURONS; POTASSIUM CHANNELS; RECEPTORS, AMPA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANS-ACTIVATION (GENETICS);

EID: 9744247581     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v16.i12.120     Document Type: Review

References (84)

1. Barbiero G, Duranti F, Bonelli G, Amenta JS, Baccino FM. (1995) Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp Cell Res 217(2):410-8.
2. Bardo MT, Robinet PM, Mattingly BA, Margulies JE. (2001) Effect of 6-hydroxydopamine or repeated amphetamine treatment on mesencephalic mRNA levels for AMPA glutamate receptor subunits in the rat. Neurosci Lett 302(2-3):133-6.
3. Benazzouz A, Piallat B, Ni ZG, Koudsie A, Pollak P, Benabid AL. (2000) Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease. Cell Transplant 9(2):215-21.
4. Bernardi P. (1996) The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275(1-2):5-9.
5. Berretta N, Paolucci E, Bernardi G, Mercuri NB. (2001) Glutamate receptor stimulation induces a persistent rhythmicity of the GABAergic inputs to rat mid-brain dopaminergic neurons. Eur J Neurosci 14(5): 777-84.
6. Birkmayer W, Hornykiewicz O. (1961, 2001). The effect of 1-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. Wien Klin Wochenschr 113(22):851-4.
7. Brundin P, Karlsson J, Emgard M, Schierle GS, Hansson O, Petersen A, Castilho RF. (2000) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant 9(2): 179-95
8. Bywood PT, Johnson SM. (2000) Loss of tyrosine hydroxylase immunoreactivity in dendrites is a sensitive index of kainic acid-induced damage in rat substantia nigra neurons in vivo. Neurosci Lett 280(1):5-8.
9. Caba E, Bahr BA. (2004) Biphasic NF-kappaB activation in the excitotoxic hippocampus. Acta Neuropathol (Berl) 2004
10. Carlsson A, Lindqvist M, Magnusson T, Waldeck B. (1958) On the presence of 3-hydroxytyramine in brain. Science 127(3296):471.
11. Cassarino DS, Halvorsen EM, Swerdlow RH, Abramova NN, Parker WD Jr, Sturgill TW, Bennett JP Jr. (2000) Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. J Neurochem 74(4):1384-92.
12. Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S, El-Metainy S, Behnke H, Mattson MP, Krieglstein J. (2003). Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J Neurosci 23(24):8586-95.
13. Dawson TM, Dawson VL. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302(5646):819-22.
14. de Erausquin GA, Costa E, Hanbauer I. (1994a) Calcium homeostasis, free radical formation, and trophic factor dependence mechanisms in Parkinson's disease. Pharmacol Rev 46(4):467-82.
15. 2+]i homeostasis in cultures of embryonic dopaminergic neurons. Brain Res Mol Brain Res 21(3-4): 303-11.
16. 2+ channels. Neurosci Lett 145(2):121-5.
17. de Erausquin GA, Hyrc K, Dorsey DA, Mamah D, Dokucu M, Masco DH, Walton T, Dikranian K, Soriano M, Garcia Verdugo JM, Goldberg MP, Dugan LL. (2003) Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons. Mol Pharmacol 63(4):784-90.
18. Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB. (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88(2):494-501
19. Dickie BG, Holmes C, Greenfield SA. (1996) Neurotoxic and neurotrophic effects of chronic N-methyl-D-aspartate exposure upon mesencephalic dopaminergic neurons in organotypic culture. Neuroscience 72(3):731-41.
20. Difazio MC, Hollingsworth Z, Young AB, Penney JB Jr. (1992) Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology 42(2):402-6.
21. Dorsey DA, Soriano M, Masciotra L, Dikranian K, García Verdugo JM, Faddis B, Hyrc K, Goldberg MP, de Erausquin GA. (2004). Ultrastructural characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced cell death in embryonic dopaminergic neurons. Mol Brain Res, submitted.
22. Dunnett SB, Bjorklund A. (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399(6738 Suppl):A32-9.
23. El-Khodor BF, Burke RE. (2002) Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J Comp Neurol 452(1):65-79.
24. Fujioka S, Schmidt C, Sclabas GM, Li Z, Pelicano H, Peng B, Yao A, Niu J, Zhang W, Evans DB, Abbruzzese JL, Huang P, Chiao PJ. (2004) Stabilization of p53: a novel mechanism for proapoptotic function of NF-kappa B. J Biol Chem.
25. Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274(5291):1383-5.
26. Grilli M, Memo M. (1999) Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ 6(1):22-7.
27. Grillner P, Mercuri NB. (2002) Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav Brain Res 130(1-2):149-69
28. Guatteo E, Federici M, Siniscalchi A, Knopfel T, Mercuri NB, Bernardi G. (1998a) Whole cell patch-clamp recordings of rat midbrain dopaminergic neurons isolate a sulphonylurea- and ATP-sensitive component of potassium currents activated by hypoxia. J Neurophysiol 79(3):1239-45.
29. Guatteo E, Mercuri NB, Bernardi G, Knopfel T. (1998b) Intracellular sodium and calcium homeostasis during hypoxia in dopamine neurons of rat substantia nigra pars compacta. J Neurophysiol 80(5): 2237-43.
30. Gustafsson B, Wigstrom H. (1981) Evidence for two types of afterhyperpolarization in CA1 pyramidal cells in the hippocampus. Brain Res 206(2):462-8.
31. Hanbauer I, Wink D, Osawa Y, Edelman GM, Gaily JA. (1992) Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport 3(5):409-12.
32. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2(9):1017-21.
33. Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y. (1997) Neuronal vulnerability in Parkinsons disease. J Neural Transm Suppl 50:79-88.
34. Holemans S, Javoy F, Agid Y, Laterre EC, Maloteaux JM. (1991) [3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy. Brain Res 565(1): 154-7.
35. Hotson JR, Prince DA. (1980) A calcium-activated hyperpolarization follows repetitive firing in hippocampal neurons. J Neurophysiol 43(2):409-19.
36. Hornykiewicz O. (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18(2):925-64.
37. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC. (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci USA 94(14):7531-6.
38. Ibi M, Sawada H, Kume T, Katsuki H, Kaneko S, Shimohama S, Akaike A. (1999) Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons. J Neurochem 73(4):1696-703.
39. Isaacs KR, de Erausquin G, Strauss KI, Jacobowitz DM, Hanbauer I. (1996) Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures. Brain Res Mol Brain Res 36(1): 114-26.
40. Jiang X, Zhu D, Okagaki P, Lipsky R, Wu X, Banaudha K, Mearow K, Strauss KI, Marini AM. (2003) N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons. Ann NY Acad Sci 993:134-45.
41. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. (1995) Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Nad Acad Sci USA 92(21):9618-22.
42. Kelly WJ, Burke RE. (1996) Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent. Neurosci Lett 220(2):85-8.
43. Klivenyi P, Andreassen OA, Ferrante RJ, Lancelot E, Reif D, Beal MF. (2000) Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport 2000 Apr 27;11(6):1265-8.
44. Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, Adelman JP. (1996) Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273(5282):1709-14.
45. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. (1999) A chemical inhibtor of p53 that protects mice from the side effects of cancer therapy. Science 285(5434):1733-7.
46. Kondoh T, Low WC. (1994) Glutamate uptake blockade induces striatal dopamine release in 6-hydroxydopamine rats with intrastriatal grafts: evidence for host modulation of transplanted dopamine neurons. Exp Neurol 127(2):191-8.
47. Kristal BS, Dubinsky JM. (1997) Mitochondrial permeability transition in the central nervous system: induction by calcium cycling-dependent and -independent pathways. J Neurochem 69(2):524-38.
48. Lancaster B, Adams PR. (1986) Calcium-dependent current generating the afterhyperpolarization of hippocampal neurons. J Neurophysiol 55(6): 1268-82.
49. Lancaster B, Nicoll RA, Perkel DJ. (1991) Calcium activates two types of potassium channels in rat hippocampal neurons in culture. J Neurosci 11(1):23-30.
50. Lemasters JJ, Qian T, Elmore SP, Trost LC, Nishimura Y, Herman B, Bradham CA, Brenner DA, Nieminen AL. (1998) Confocal microscopy of the mitochondrial permeability transition in necrotic cell killing, apoptosis and autophagy. Biofactors 8(3-4):283-5
51. Lui PW, Suen KC, Chan YS, Yung WH, Yung KK. (2003) Striatal neurons but not nigral dopaminergic neurons in neonatal primary cell culture express endogenous functional N-methyl-D-aspartate receptors. Brain Res Mol Brain Res 120(1):9-21.
52. Macaya A, Munell F, Gubits RM, Burke RE. (1994) Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci USA 91(17):8117-21
53. Marinelli S, Bernardi G, Giacomini P, Mercuri NB. (2000) Pharmacological identification of the K(+) currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones. Neuropharmacology 39(6):1021-8.
54. Marti MJ, James CJ, Oo TF, Kelly WJ, Burke RE. (1997) Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci 17(6): 2030-9.
55. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL. (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53(2):327-58.
56. Mattson MP, Culmsee C, Yu Z, Camandola S. (2000) Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem 74(2):443-56.
57. McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW. (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179(1): 38-46.
58. Mercuri NB, Stratta F, Calabresi P, Bernardi G. (1992) A voltage-clamp analysis of NMDA-induced responses on dopaminergic neurons of the rat substantia nigra zona compacta and ventral tegmental area. Brain Res 593(1):51-6.
59. Mercuri NB, Stratta F, Calabresi P, Bonci A, Bernardi G. (1993) Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons. Neuroscience 56(2):399-407.
60. Mercuri NB, Bonci A, Calabresi P, Stratta F, Bernardi G. (1994) Responses of rat mesencephalic dopaminergic neurons to a prolonged period of oxygen deprivation. Neuroscience 63(3):757-64.
61. Mereu G, Costa E, Armstrong DM, Vicini S. (1991) Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J Neurosci 11(5):1359-66.
62. Mohanakumar KP, Hanbauer I, Chiueh CC. (1998) Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity. J Chem Neuroanat 14(3-4):195-205.
63. Oo TF, Burke RE. (1997) The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Brain Res Dev Brain Res 98(2):191-6
64. Paquet M, Tremblay M, Soghomonian JJ, Smith Y. (1997) AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 17(4):1377-96.
65. Pizzi M, Goffi F, Boroni F, Benarese M, Perkins SE, Liou HC, Spano P. (2002) Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J Biol Chem 277(23): 20717-23.
66. Rodriguez MC, Obeso JA, Olanow CW. (1998) Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44(3 Suppl 1):S175-88.
67. Ryan KM, Ernst MK, Rice NR, Vousden KH. (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404(6780):892-7.
68. Sah P. (1995) Properties of channels mediating the apamin-insensitive afterhyperpolarization in vagal motoneurons. J Neurophysiol 74(4):1772-6.
69. Sah P, McLachlan EM. (1991) Ca(2+)-activated K+ currents underlying the afterhyperpolarization in guinea pig vagal neurons: a role for Ca(2+)-activated Ca2+ release. Neuron 7(2):257-64.
70. Sarmiere PD, Freeman RS. (2001) Analysis of the NF-kappa B and PI3-kinase/Akt survival pathways in nerve growth factor-dependent neurons. Mol Cell Neurosci 18(3):320-31.
71. Schierle GS, Karlsson J, Brundin P. (1998) MK-801 does not enhance dopaminergic cell survival in embryonic nigral grafts. Neuroreport 9(7):1313-6.
72. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5(5):554-9.
73. Schweizer M, Richter C. (1994) Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 204(1): 169-75.
74. Sesack SR, Carr DB, Omelchenko N, Pinto A. (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann NY Acad Sci 1003:36-52.
75. Seutin V, Johnson SW, North RA. (1993) Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res 630(1-2):341-4.
76. Silva NL, Pechura CM, Barker JL. (1990) Postnatal rat nigrostriatal dopaminergic neurons exhibit five types of potassium conductances. J Neurophysiol 64(1): 262-72.
77. Stocker M, Pedarzani P. (2000) Differential distribution of three Ca(2+)-activated K(+) channel subunits, SK1, SK2, and SK3, in the adult rat central nervous system. Mol Cell Neurosci 15(5):476-93.
78. Szekely AM, Costa E, Grayson DR. (1990). Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons. Mol Pharmacol 38(5):624-33.
79. Tacconi S, Carletti R, Bunnemann B, Plumpton C, Merlo Pich E, Terstappen GC. (2001) Distribution of the messenger RNA for the small conductance calcium-activated potassium channel SK3 in the adult rat brain and correlation with immunoreactivity. Neuroscience 102(1):209-15.
80. Tallaksen-Greene SJ, Wiley RG, Albin RL. (1992) Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res 594(1):165-70.
81. Viana F, Bayliss DA, Berger AJ. (1993) Multiple potassium conductances and their role in action potential repolarization and repetitive firing behavior of neonatal rat hypoglossal motoneurons. J Neurophysiol 69(6):2150-63.
82. Wolfart J, Neuhoff H, Franz O, Roeper J. (2001) Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pace-maker control in dopaminergic midbrain neurons. J Neurosci 21(10):3443-56.
83. Wu J, Partridge LD. (1998) Dissociated dopaminergic neurons from substantia nigra zona compacta in young rats lack functional NMDA receptors. Pflugers Arch 435(5):699-704.
84. Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LM, Farhangrazi ZS, Ying HS, Tian M, Dugan LL, Choi DW. (1997) Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 278(5335):114-7.